NLRP3 and relapsing-remitting multiple sclerosis: Expression levels of NLRP3 mRNA in PBMCs correlate with disease relapse in RRMS patients (43), and ex vivo stimulation of PBMCs from primary progressive MS patients also showed enhanced NLRP3 expression and activation (44).